Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012;7(3):e32652.
doi: 10.1371/journal.pone.0032652. Epub 2012 Mar 13.

Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis

Affiliations
Comparative Study

Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis

Yun Feng et al. PLoS One. 2012.

Abstract

Background: The diagnosis of tuberculosis remains difficult. This study aimed to assess performance of interferon-gamma release assay (IGRA) in diagnosis of active tuberculosis (ATB) with pulmonary and extrapulmonary involvements, and to determine the diagnostic role of IGRA (T-SPOT.TB) and tuberculin skin test (TST) in BCG-vaccinated population.

Methods and findings: Two hundred twenty-six ATB suspects were recruited and examined with T-SPOT.TB. Among them, fifty-two and seventy-six subjects were simultaneously tested by TST with 5TU or 1TU of purified protein derivative (PPD). The sensitivity of T-SPOT.TB was 94.7% (71/75), comparable in pulmonary and extrapulmonary disease groups (95.6% vs. 93.3%, P>0.05), while the specificity was 84.10% (90/107) but differed in two groups (69.2% vs. 88.9%, P = 0.02). Compared to T-SPOT.TB, TST with 5TU-PPD showed less sensitivity (92.3% vs. 56.4%) and specificity (84.6% vs. 61.5%) (both P<0.01); the sensitivity of TST with 1TU-PPD was 27.8%, and despite its specificity identical to T-SPOT.TB (both 82.8%) positive predictive value (PPV) was only 33.3%. By combining T-SPOT.TB with TST (1TU), the specificity rose to 95%, but the PPV stayed unchanged.

Conclusions: IGRA could function as a powerful immunodiagnostic test to explore pulmonary and extrapulmonary TB, while TST failed to play a reliable or auxiliary role in identifying TB disease and infection in the BCG-vaccinated population.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flowchart of the study population.
A total of 226 subjects suspected to have active tuberculosis (ATB) were recruited and 182 were eligible to be included in the final analyses. The analyses were composed of two parts: a study on the diagnostic performance of the T-SPOT.TB on pulmonary and extrapulmonary ATB, and a study comparing the performance between T-SPOT.TB and TST with a dose of 1TU-PPD or 5TU-PPD. ATB, active tuberculosis; no ATB, final diagnosis excluded active tuberculosis.
Figure 2
Figure 2. The deviation features of the T-SPOT.TB, TST in single or combination way.
The deviation from the gold standard test was compared between T-SPOT.TB and TST1TU PPD (A), T-SPOT.TB and TST5TU PPD (B), and between the combination in parallel and serial way for these two comparisons (C, D). The north, south, east and west poles in each panel represented 100%of the true-positive rate, true-negative rate, false-positive rate, and false-negative rate, respectively, and each observed rate located between the top poles of the axes (100%) and the central origin (0%). In A and B, the shape formed by connecting the diagnostic rates of T-SPOT.TB was outlined by the dark lines and the shape of TST were filled with grey color. In C and D, parallel testing was outlined by dashed lines, and serial testing by dotted lines.

References

    1. Siu GK, Zhang Y, Lau TC, Lau RW, Ho PL, et al. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2011;66:730–733. - PubMed
    1. Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005;26:247–271, vi. - PubMed
    1. Cohn DL, O'Brien RJ, Geiter LJ, Gordin FM, Hershfield E, et al. Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection. American Journal of Respiratory and Critical Care Medicine. 2000;161:S221–S247. - PubMed
    1. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2006;174:736–742. - PubMed
    1. Jiang W, Shao L, Zhang Y, Zhang S, Meng C, et al. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol. 2009;10:31. - PMC - PubMed

Publication types